ACER.png
Acer Therapeutics to Present at UBS Global Healthcare Conference
07 mai 2019 08h30 HE | Acer Therapeutics Inc.
NEWTON, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious...
ACER.png
Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data
16 avr. 2019 08h30 HE | Acer Therapeutics Inc.
NEWTON, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...
ACER.png
CORRECTING and REPLACING -- Acer Therapeutics to Participate in Upcoming Investor Conferences
13 mars 2019 11h17 HE | Acer Therapeutics Inc.
In a release issued earlier today by Acer Therapeutics Inc. (Nasdaq: ACER), please note in the table for the Roth Capital Partners 31st Annual Growth Stock Conference, a time of 3:30 pm Pacific Time...
ACER.png
Acer Therapeutics to Participate in Upcoming Investor Conferences
13 mars 2019 08h30 HE | Acer Therapeutics Inc.
NEWTON, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...
ACER.png
Acer Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
07 mars 2019 16h01 HE | Acer Therapeutics Inc.
NEWTON, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...
ACER Logo.jpg
Acer Therapeutics Announces In-license of Osanetant from Sanofi
02 janv. 2019 08h30 HE | Acer Therapeutics Inc.
NEWTON, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...
ACER Logo.jpg
Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO™ for the Treatment of vEDS
26 déc. 2018 08h30 HE | Acer Therapeutics Inc.
Acer continues progress toward goal of commercializing EDSIVO™ NEWTON, Mass., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the...
ACER Logo.jpg
Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer
17 déc. 2018 08h30 HE | Acer Therapeutics Inc.
Seasoned veteran brings two decades of commercial experience to Acer Acer continues to execute on activities towards its goal of commercializing EDSIVO™ NEWTON, Mass., Dec. 17, 2018 (GLOBE...
ACER Logo.jpg
Acer Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
09 nov. 2018 16h01 HE | Acer Therapeutics Inc.
Acer continues to progress towards goal of commercializing EDSIVO™ Company appoints VPs of Corporate Development and IT & Database Administrator NEWTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE)...
ACER Logo.jpg
Acer Therapeutics to Present at the Evercore ISI HealthConX Conference
08 nov. 2018 08h30 HE | Acer Therapeutics Inc.
NEWTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...